Activity from announced rounds
RegCell is developing cell therapies for autoimmune disease by epigenetically reprogramming pathogenic conventional T cells into stable regulatory T cells, aiming to restore immune tolerance without gene engineering; its platform is advancing toward clinical development.
AI security and governance platform purpose-built for enterprise AI agents
Helps platform teams and cloud providers modernize and manage infrastructure for the AI era
Provides a comprehensive privacy platform that empowers individuals to reclaim control of their p...
Provides AI observability and security platform for enterprises